glutathione synthetase deficiency prevalence system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis Glutathione synthetase deficiency | MedLink
Description
EFSA Panel on Biological Hazards (BIOHAZ), Koutsoumanis K, Allende A, et al
doi:10.1016/j.cell.2015.06.054 pmid:26232230 Koju N, Taleb A, Zhou J, Lv G, Yang J, Cao X, Lei H, Ding Q (2019) Pharmacological strategies to lower crosstalk between nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and mitochondria
Ooi CY, 2020, 'The intestinal virome in children with cystic fibrosis differs from healthy controls', in Plos One , Vol
Termin vereinbaren Bereit fr den ersten Schritt
